Cancer‐Cell‐Activated In‐Situ Synthesis of Mitochondria‐Targeting AIE Photosensitizer for Precise Photodynamic Therapy

2021 ◽  
Author(s):  
Yuanbo Wang ◽  
Shidang Xu ◽  
Leilei Shi ◽  
Cathleen Teh ◽  
Guobin Qi ◽  
...  
2018 ◽  
Vol 54 (24) ◽  
pp. 2962-2965 ◽  
Author(s):  
Zhimei He ◽  
Yan Xiao ◽  
Jian-Rong Zhang ◽  
Penghui Zhang ◽  
Jun-Jie Zhu

Endogenous H+-/H2O2-triggered nanohybrids for cancer cell-specific and O2 self-sufficient PDT: a promising platform for effective PDT against tumor hypoxia.


2021 ◽  
Vol 22 (19) ◽  
pp. 10506
Author(s):  
Dimakatso R. Mokoena ◽  
Blassan P. George ◽  
Heidi Abrahamse

Breast cancer is the second most common cancer globally and the pioneering cause of mortality among women. It usually begins from the ducts or lobules, referred to as ductal carcinoma in situ, or lobular carcinoma in situ. Age, mutations in Breast Cancer Gene 1 or 2 (BRCA1 or BRCA2) genes, and dense breast tissue are the highest risk factors. Current treatments are associated with various side effects, relapse, and a low quality of life. Although conventional treatments, such as surgery and chemotherapy, have been used for decades, their adverse side effects on normal cells and tissues pose a major weakness, which calls for a non-invasive treatment option. Photodynamic therapy (PDT) has proven to be a promising form of cancer therapy. It is less invasive, target-specific, and with reduced cytotoxicity to normal cells and tissues. It involves the use of a photosensitizer (PS) and light at a specific wavelength to produce reactive oxygen species. One of the reasons for the target specificity is associated with the dense vascularization of cancer tissues, which tends to increase the surface area for the PS uptake. Photosensitizers are light-sensitive molecules, which result in cancer cell destruction followed by light irradiation. Depending on the localization of the PS within the cancer cell, its destruction may be via apoptosis, necrosis, or autophagy. This review focuses on the breast cancer etiopathology and PDT-induced cell death mechanisms in breast cancer cells.


Nanoscale ◽  
2018 ◽  
Vol 10 (48) ◽  
pp. 22937-22945 ◽  
Author(s):  
Xiaoli Cai ◽  
Yanan Luo ◽  
Yang Song ◽  
Dong Liu ◽  
Hongye Yan ◽  
...  

A mitochondria-targeting and O2-evolving PDT nanoplatform based on 3D-dendritic MSNs was proposed for highly efficient cancer PDT treatment.


2020 ◽  
Vol 56 (96) ◽  
pp. 15208-15211
Author(s):  
Zhuolin Fu ◽  
Yingdi Wu ◽  
Chunnian Ren ◽  
Weiling Song ◽  
Xiaoru Zhang ◽  
...  

A novel multifunctional nanoprobe was designed for cancer cell targeted multilayer imaging of two cancer biomarkers. And in situ imaging of membrane MUC1 mucin and cytoplasmic microRNA miR-21 coupled with precise photodynamic therapy was achieved.


2020 ◽  
Vol 8 (14) ◽  
pp. 3994-4002
Author(s):  
Huachao Chen ◽  
Chengkun He ◽  
Tianyi Chen ◽  
Xuling Xue

This work reports new ROS-responsive and O2-producing nanoparticles to achieve selective and mitochondria-targeted PDT for cancer treatment against hypoxic tumors.


2013 ◽  
Vol 30 (6) ◽  
pp. 667
Author(s):  
Zhenzhen WANG ◽  
Fangfang LI ◽  
Han GUO ◽  
Jiuju FENG ◽  
Aijun WANG

2017 ◽  
Vol 101 (3) ◽  
pp. 1371-1380 ◽  
Author(s):  
Tao Li ◽  
Yulei Zhang ◽  
Jia Sun ◽  
Jincui Ren ◽  
Pengfei Zhang ◽  
...  

2021 ◽  
Vol 546 ◽  
pp. 149019
Author(s):  
Bao Jin ◽  
Jun Zhao ◽  
Guangyan Chen ◽  
Yongyong He ◽  
Yiyao Huang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document